trending Market Intelligence /marketintelligence/en/news-insights/trending/xtnjheug3i-ktderrpqrfw2 content esgSubNav
In This List

WuXi Biologics to build manufacturing facility in northern China

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


WuXi Biologics to build manufacturing facility in northern China

WuXi Biologics (Cayman) Inc. said it will build an integrated biologics facility in Shijiazhuang, the capital of China's Hebei province.

Biologics centers develop and manufacture biologic medical products using living microorganisms, plants or animal cells.

WuXi Biologics said the initial phase of the center is expected to be operational in 2020.

China-based WuXi Biologics is a provider of discovery, research, development and manufacturing of biologics services.